CPA
GCO icon

Capital Performance Advisors’s Genesco GCO Stock Holding History

Capital Performance Advisors’s Portfolio GCO Stock Details GCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-113
Closed -$3.07K – 1117
2024
Q3 		$3.07K Buy
+113
New +$3.14K ﹤0.01% 1348

Other funds holding GCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Performance Advisors's GCO Position: Q4 2024 in Review

Capital Performance Advisors sold out of Genesco (GCO) in Q4 2024, closing a stake of 113 shares — an estimated $3.07K sold.

Capital Performance Advisors first reported a position in GCO in Q3 2024 and held it in 1 quarter. The position peaked at $3.07K in Q3 2024. 133 funds tracked by Wall St. Rank hold GCO as of Q4 2024.

  • Capital Performance Advisors reported no remaining Genesco position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 113 Genesco shares in Q4 2024, an estimated $3.07K.
  • Capital Performance Advisors first reported a position in Genesco in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Genesco position peaked at $3.07K in Q3 2024.
  • 133 funds tracked by Wall St. Rank held Genesco as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.